ORAL CIPROFLOXACIN THERAPY OF INFECTION CAUSED BY MULTIPLY RESISTANT-BACTERIA OTHER THAN PSEUDOMONAS-AERUGINOSA

被引：29

作者：

SCULLY, BE

NEU, HC

机构：

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1986年 / 18卷

关键词：

D O I：

10.1093/jac/18.Supplement_D.179

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：179 / 185

页数：7

共 10 条

[1] INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].

BAUERNFEIND, A ;

PETERMULLER, C .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115

[2]

BLUMER JL, 1985, 14TH P INT C CHEM KY

[3] THE PHARMACOKINETICS AND SERUM AND URINE BACTERICIDAL ACTIVITY OF CIPROFLOXACIN [J].

BRITTAIN, DC ;

SCULLY, BE ;

MCELRATH, MJ ;

STEINMAN, R ;

LABTHAVIKUL, P ;

NEU, HC .

JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (02) :82-88

[4] CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].

CHIN, NX ;

NEU, HC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :319-326

[5] PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN [J].

CRUMP, B ;

WISE, R ;

DENT, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :784-786

[6]

FONG IW, 1985, 14TH P INT C CHEM KY

[7] MULTIPLE-DOSE PHARMACOKINETICS OF CIPROFLOXACIN ADMINISTERED INTRAVENOUSLY TO NORMAL VOLUNTEERS [J].

GONZALEZ, MA ;

MORANCHEL, AH ;

DURAN, S ;

PICHARDO, A ;

MAGANA, JL ;

PAINTER, B ;

FORREST, A ;

DRUSANO, GL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) :235-239

[8]

SCHALKAUSER K, 1985, 14TH P INT C CHEM KY

[9]

SCULLY BE, 1986, LANCET, V1, P819

[10] INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J].

WISE, R ;

ANDREWS, JM ;

EDWARDS, LJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) :559-564

← 1 →